When clinical practice guidelines meet the black box

Archives of Internal Medicine

Volumn 170, Issue 12, 2010, Pages 1013-1014

  Avins, Andrew L ^a  

^a DIVISION OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; DIABETES MELLITUS; EDITORIAL; EVIDENCE BASED MEDICINE; GLUCOSE BLOOD LEVEL; HYPERLIPIDEMIA; HYPERTENSION; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EVIDENCE-BASED EMERGENCY MEDICINE; GUIDELINE ADHERENCE; HUMANS; MODELS, BIOLOGICAL; PRACTICE GUIDELINES AS TOPIC;

EID: 77954205490     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2010.185     Document Type: Editorial

References (11)

1. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999;318(7182):527-530.
2. Sanders GD, Parmar PK. Use of decision models in clinical-practice guideline development. Abstr Acad Health Serv Res Health Policy Meet. 2001;18:184.
3. Diehl AK. Cost-effectiveness of ursodiol: the creature from the black box. J Gen Intern Med. 1990;5(4):374-375.
4. Timbie JW, Hayward RA, Vijan S. Variation in the net benefit of aggressive cardiovascular risk factor control across the US population of patients with diabetes mellitus. Arch Intern Med. 2010;170(12):1037-1044.
5. American Diabetes Association. Standards of medical care in diabetes: 2010. Diabetes Care. 2010;33(suppl 1):S11-S61.
6. Chobanian AV, Bakris GL, Black HR, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-2572.
7. Nilsson PM. ACCORD and risk-factor control in type 2 diabetes [published online March 14, 2010]. N Engl J Med. 2010. doi:10.1056/NEJMe1002498.
8. ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1563-1574.
9. ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1575-1585.
10. Avins AL, Browner WS. Lowering risk without lowering cholesterol: implications for national cholesterol policy. Ann Intern Med. 1996;125(6):502-506.
11. Wu J, Kraja AT, Oberman A, et al. A summary of the effects of antihypertensive medications on measured blood pressure. Am J Hypertens. 2005;18(7):935-942.